PFIZER INC Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
PFIZER INC (PFE) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of $8.00 million for the 3-month period ending 2020-09-27, per its 10-Q filed 2020-11-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2020-11-05
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2020-09-27 was $8.00M, a 100.00% increase year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2020-06-28 was $8.00M, a 20.00% decline year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2020-03-29 was $9.00M, a 50.00% increase year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2019-12-31 was $10.00M, a 9.09% decline year-over-year.
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2019 was $29.00M, a 19.44% decline from fiscal 2018.
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2018 was $36.00M, a 23.40% decline from fiscal 2017.
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2017 was $47.00M, a 51.61% increase from fiscal 2016.
- PFIZER INC income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2016 was $31.00M, a 19.23% increase from fiscal 2015.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-09-27 | $8.00M 10-Q · filed 2020-11-05 | $16.00M derived: sum of 2 quarters · filed 2020-11-05 | $25.00M 10-Q · filed 2020-11-05 | $35.00M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-28 | $8.00M 10-Q · filed 2020-08-06 | $17.00M 10-Q · filed 2020-08-06 | $27.00M derived: sum of 3 quarters · filed 2020-08-06 | $31.00M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-03-29 | $9.00M 10-Q · filed 2020-05-07 | $19.00M derived: sum of 2 quarters · filed 2020-05-07 | $23.00M derived: sum of 3 quarters · filed 2020-11-05 | $33.00M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $14.00M derived: sum of 2 quarters · filed 2020-11-05 | $24.00M derived: sum of 3 quarters · filed 2020-11-05 | $29.00M 10-K · filed 2020-02-27 |
| 2019-09-29 | $4.00M 10-Q · filed 2020-11-05 | $14.00M derived: sum of 2 quarters · filed 2020-11-05 | $19.00M 10-Q · filed 2020-11-05 | $31.00M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $10.00M 10-Q · filed 2020-08-06 | $15.00M 10-Q · filed 2020-08-06 | $27.00M derived: sum of 3 quarters · filed 2020-08-06 | $35.00M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $6.00M 10-Q · filed 2020-05-07 | $17.00M derived: sum of 2 quarters · filed 2020-05-07 | $25.00M derived: sum of 3 quarters · filed 2020-05-07 | $32.00M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $19.00M derived: sum of 2 quarters · filed 2020-02-27 | $26.00M derived: sum of 3 quarters · filed 2020-02-27 | $36.00M 10-K · filed 2020-02-27 |
| 2018-09-30 | $8.00M 10-Q · filed 2019-11-07 | $15.00M derived: sum of 2 quarters · filed 2019-11-07 | $25.00M 10-Q · filed 2019-11-07 | $39.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-07-01 | $7.00M 10-Q · filed 2019-08-08 | $16.00M 10-Q · filed 2019-08-08 | $31.00M derived: sum of 3 quarters · filed 2020-02-27 | $49.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-04-01 | $9.00M 10-Q · filed 2019-05-09 | $24.00M derived: sum of 2 quarters · filed 2020-02-27 | $42.00M derived: sum of 3 quarters · filed 2020-02-27 | $47.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $33.00M derived: sum of 2 quarters · filed 2020-02-27 | $38.00M derived: sum of 3 quarters · filed 2020-02-27 | $47.00M 10-K · filed 2020-02-27 |
| 2017-10-01 | $18.00M 10-Q · filed 2018-11-08 | $23.00M derived: sum of 2 quarters · filed 2018-11-08 | $32.00M 10-Q · filed 2018-11-08 | $38.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-07-02 | $5.00M 10-Q · filed 2018-08-09 | $14.00M 10-Q · filed 2018-08-09 | $20.00M derived: sum of 3 quarters · filed 2019-02-28 | $20.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-04-02 | $9.00M 10-Q · filed 2018-05-10 | $15.00M derived: sum of 2 quarters · filed 2019-02-28 | $15.00M derived: sum of 3 quarters · filed 2019-02-28 | $31.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $6.00M derived: sum of 2 quarters · filed 2019-02-28 | $22.00M derived: sum of 3 quarters · filed 2019-02-28 | $31.00M 10-K · filed 2019-02-28 |
| 2016-10-02 | $0.00 10-Q · filed 2017-11-09 | $16.00M derived: sum of 2 quarters · filed 2017-11-09 | $25.00M 10-Q · filed 2017-11-09 | $28.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-07-03 | $16.00M 10-Q · filed 2017-08-10 | $25.00M 10-Q · filed 2017-08-10 | $28.00M derived: sum of 3 quarters · filed 2018-02-22 | $37.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-04-03 | $9.00M 10-Q · filed 2017-05-11 | $12.00M derived: sum of 2 quarters · filed 2018-02-22 | $21.00M derived: sum of 3 quarters · filed 2018-02-22 | $30.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $12.00M derived: sum of 2 quarters · filed 2018-02-22 | $21.00M derived: sum of 3 quarters · filed 2018-02-22 | $26.00M 10-K · filed 2018-02-22 |
| 2015-09-27 | $9.00M 10-Q · filed 2016-11-10 | $18.00M derived: sum of 2 quarters · filed 2016-11-10 | $23.00M 10-Q · filed 2016-11-10 | $31.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-28 | $9.00M 10-Q · filed 2016-08-11 | $14.00M 10-Q · filed 2016-08-11 | $22.00M derived: sum of 3 quarters · filed 2017-02-23 | $28.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-29 | $6.00M 10-Q · filed 2016-05-12 | $13.00M derived: sum of 2 quarters · filed 2017-02-23 | $19.00M derived: sum of 3 quarters · filed 2017-02-23 | $28.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $13.00M derived: sum of 2 quarters · filed 2017-02-23 | $22.00M derived: sum of 3 quarters · filed 2017-02-23 | $32.00M 10-K · filed 2017-02-23 |
| 2014-09-28 | $6.00M 10-Q · filed 2015-11-05 | $15.00M derived: sum of 2 quarters · filed 2015-11-05 | $25.00M 10-Q · filed 2015-11-05 | $29.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-29 | $9.00M 10-Q · filed 2015-08-06 | $18.00M 10-Q · filed 2015-08-06 | $23.00M derived: sum of 3 quarters · filed 2016-02-29 | $29.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-30 | $9.00M 10-Q · filed 2015-05-07 | $14.00M derived: sum of 2 quarters · filed 2016-02-29 | $20.00M derived: sum of 3 quarters · filed 2016-02-29 | $30.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $11.00M derived: sum of 2 quarters · filed 2016-02-29 | $21.00M derived: sum of 3 quarters · filed 2016-02-29 | $30.00M 10-K · filed 2016-02-29 |
| 2013-09-29 | $6.00M 10-Q · filed 2014-11-06 | $16.00M derived: sum of 2 quarters · filed 2014-11-06 | $25.00M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $10.00M 10-Q · filed 2014-08-07 | $19.00M 10-Q · filed 2014-08-07 | ||
| 2012-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $12.00M derived: sum of 2 quarters · filed 2015-02-27 | $19.00M derived: sum of 3 quarters · filed 2015-02-27 | $28.00M 10-K · filed 2015-02-27 |
| 2012-09-30 | $6.00M 10-Q · filed 2013-11-08 | $13.00M derived: sum of 2 quarters · filed 2013-11-08 | $22.00M 10-Q · filed 2013-11-08 | |
| 2012-07-01 | $7.00M 10-Q · filed 2013-08-09 | $16.00M 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |